Clinical trial
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a…
NCT00135694 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00135694 |
|---|---|
| Title | Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant |
| Official title | A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients |
| Acronym | A-WISH |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Immune Tolerance Network (ITN) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis C, Chronic, Nonimmune Nonviral Causes of Liver Failure |
| Intervention type | Drug, Other, Procedure |
| Interventions | calcineurin inhibitor-based immunosuppression, liver transplant, corticosteroids, immunosuppression withdrawal |
| Enrollment | 275 |
| Start date | Oct 1, 2005 |
| Primary completion | Sep 1, 2015 |
| Completion | Sep 1, 2015 |
| First posted | Aug 26, 2005 |
| Last update posted | Feb 4, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: